Skip Navigation

Radiation Protection Dosimetry 2004 110(1-4):607-612; doi:10.1093/rpd/nch135
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vanhavere, F.
Right arrow Articles by Struelens, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanhavere, F.
Right arrow Articles by Struelens, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Radiation Protection Dosimetry Vol. 110 Nos. 1-4 © Oxford University Press 2004; all rights reserved

Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator

F. Vanhavere1,*, D. Huyskens2 and L. Struelens1

1 SCK-CEN, Belgian Nuclear Research Centre, 2400 Mol, Belgium
2 University Hospital Leuven, Radiation Physics Department, 3000 Leuven, Belgium

* Corresponding author: fvanhave{at}sckcen.be

More and more attention is being given in radiotherapy to the doses received by organs other than the target organ. With increasing survival time of the patients, the risks of secondary malignancies need to be lowered as much as possible. So total body doses are worth estimating in radiotherapy. The introduction of intensity modulated radiotherapy (IMRT) needs an increase in the number of monitor units given to the patient. So there is a risk of increasing the peripheral doses using this technique. Another aspect, mostly neglected, is the neutron peripheral dose that occurs when LINAC energies above 8 MeV are used.

We did measurements for both gammas and neutrons with an 18 MV Varian accelerator for a prostate cancer treatment. The measurements were done both free-in-air, at different depths in a plexi-phantom, and using a Rando–Alderson phantom. Effective doses for the total body outside the treatment area are estimated using these measurements.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Radiat Prot DosimetryHome page
M. Kralik, K. Turek, and V. Vondracek
Spectra of photoneutrons produced by high-energy X-ray radiotherapy linacs
Radiat Prot Dosimetry, December 1, 2008; 132(1): 13 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
B. Wang and X. G. Xu
Measurements of non-target organ doses using MOSFET dosemeters for selected IMRT and 3D CRT radiation treatment procedures
Radiat Prot Dosimetry, February 1, 2008; 128(3): 336 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
W. F. Rebello, A. X. Silva, and A. Facure
Multileaf shielding design against neutrons produced by medical linear accelerators
Radiat Prot Dosimetry, January 1, 2008; 128(2): 227 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
F. d'Errico
Status of radiation detection with superheated emulsions
Radiat Prot Dosimetry, September 1, 2006; 120(1-4): 475 - 479.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.